Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan

计划入组 1,349 人 · 首次发布于 2016 年 5 月 18 日

TIRCON International NBIA Registry

计划入组 2,000 人 · 首次发布于 2022 年 8 月 31 日

Chia Seeds Consumption in Hypertriglyceridemia

计划入组 66 人 · 首次发布于 2023 年 9 月 1 日

NHI-Glc-2

Ramucirumab biosimilar (Chia-tai Tianqing)

Liraglutide biosimilar (Chia Tai Tianqing)

NHI-1

United States

Jiangsu Nhwa Pharmaceutical Co., Ltd.

China

PETER CHIA MARKETING PTE. LTD.

Singapore

NHIA and Roche Expand Partnership to Reduce Cancer Treatment Costs in Nigeria

Taiwan to Expand National Health Insurance Coverage for Cancer Immunotherapies and Targeted Drugs

Taiwan Approves NT$100 Million Gene Therapy for Rare AADC Deficiency Amid Coverage Debate